PRTA FY 2021 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$201M+23414.3% YoY

Gross Profit

$201M100.0% margin

Operating Income

$72M35.9% margin

Net Income

$67M33.4% margin

EPS (Diluted)

$1.38

Cash Flow

Operating Cash Flow

$93M

Free Cash Flow

$92M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$609M

Total Liabilities

$143M

Stockholders' Equity

$466M

Cash & Equivalents

$579M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$201M	$853,000	+23414.3%
Gross Profit	$201M	-$74M	+370.9%
Operating Income	$72M	-$113M	+163.8%
Net Income	$67M	-$111M	+160.3%